ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

“We Want Our Voices To Be Heard” Coalition Tells NCAB; Seeks Seats On Advisory Board

January 1, 1993

In Brief: Moffitt Center Makes Major Recruitment Effort; Komen Foundation Invites Award Nominations

May 28, 1993

HHS Forms Office for Recovery Act

March 13, 2009

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

January 27, 2012

NCI To Require Reports On Adverse Drug Reactions From Trials

June 10, 1994

Authorizes $2.7 Billion For NCI, 7% Prevention

May 28, 1993